 | • レポートコード：MRC2102QY4235 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、137ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：材料、化学 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のジヒドロアルテミシニン市場について種類別（医薬品用、工業用）、用途別（マラリア治療、科学研究、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ジヒドロアルテミシニン市場の概要 ・世界の主要地域別ジヒドロアルテミシニン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のジヒドロアルテミシニン市場規模2015-2026：種類別（医薬品用、工業用） ・世界のジヒドロアルテミシニン市場規模2015-2026：用途別（マラリア治療、科学研究、その他） ・ジヒドロアルテミシニンの米国市場規模2015-2020 ・ジヒドロアルテミシニンのヨーロッパ市場規模2015-2020 ・ジヒドロアルテミシニンの中国市場規模2015-2020 ・ジヒドロアルテミシニンの日本市場規模2015-2020 ・ジヒドロアルテミシニンの東南アジア市場規模2015-2020 ・ジヒドロアルテミシニンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ジヒドロアルテミシニンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ジヒドロアルテミシニンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Dihydroartemisinin Market
The global Dihydroartemisinin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Dihydroartemisinin Scope and Market Size
The global Dihydroartemisinin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dihydroartemisinin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Dihydroartemisinin market is segmented into
Pharmaceutical Grade
Industrial Grade
Segment by Application, the Dihydroartemisinin market is segmented into
Malaria Treatment
Scientific Research
Others
The Dihydroartemisinin market is analysed and market size information is provided by regions (countries). Segment by Application, the Dihydroartemisinin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Dihydroartemisinin Market Share Analysis
Dihydroartemisinin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Dihydroartemisinin business, the date to enter into the Dihydroartemisinin market, Dihydroartemisinin product introduction, recent developments, etc.
The major vendors covered:
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
1 Dihydroartemisinin Market Overview
1.1 Dihydroartemisinin Product Scope
1.2 Dihydroartemisinin Segment by Type
1.2.1 Global Dihydroartemisinin Sales by Type (2020-2026)
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Dihydroartemisinin Segment by Application
1.3.1 Global Dihydroartemisinin Sales Comparison by Application (2020-2026)
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Dihydroartemisinin Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dihydroartemisinin Sales Growth Rate (2015-2026)
1.4.2 Global Dihydroartemisinin Revenue and Growth Rate (2015-2026)
1.4.3 Global Dihydroartemisinin Price Trends (2015-2026)
2 Dihydroartemisinin Estimate and Forecast by Region
2.1 Global Dihydroartemisinin Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dihydroartemisinin Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dihydroartemisinin Sales Market Share by Region (2015-2020)
2.2.2 Global Dihydroartemisinin Revenue Market Share by Region (2015-2020)
2.3 Global Dihydroartemisinin Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dihydroartemisinin Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dihydroartemisinin Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dihydroartemisinin Estimates and Projections (2015-2026)
2.4.2 Europe Dihydroartemisinin Estimates and Projections (2015-2026)
2.4.3 China Dihydroartemisinin Estimates and Projections (2015-2026)
2.4.4 Japan Dihydroartemisinin Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dihydroartemisinin Estimates and Projections (2015-2026)
2.4.6 India Dihydroartemisinin Estimates and Projections (2015-2026)
3 Global Dihydroartemisinin Competition Landscape by Players
3.1 Global Top Dihydroartemisinin Players by Sales (2015-2020)
3.2 Global Top Dihydroartemisinin Players by Revenue (2015-2020)
3.3 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2019)
3.4 Global Dihydroartemisinin Average Price by Company (2015-2020)
3.5 Manufacturers Dihydroartemisinin Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dihydroartemisinin Players (Opinion Leaders)
4 Global Dihydroartemisinin Market Size by Type
4.1 Global Dihydroartemisinin Historic Market Review by Type (2015-2020)
4.1.1 Global Dihydroartemisinin Sales Market Share by Type (2015-2020)
4.1.2 Global Dihydroartemisinin Revenue Market Share by Type (2015-2020)
4.1.3 Global Dihydroartemisinin Price by Type (2015-2020)
4.2 Global Dihydroartemisinin Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dihydroartemisinin Sales Forecast by Type (2021-2026)
4.2.2 Global Dihydroartemisinin Revenue Forecast by Type (2021-2026)
4.2.3 Global Dihydroartemisinin Price Forecast by Type (2021-2026)
5 Global Dihydroartemisinin Market Size by Application
5.1 Global Dihydroartemisinin Historic Market Review by Application (2015-2020)
5.1.1 Global Dihydroartemisinin Sales Market Share by Application (2015-2020)
5.1.2 Global Dihydroartemisinin Revenue Market Share by Application (2015-2020)
5.1.3 Global Dihydroartemisinin Price by Application (2015-2020)
5.2 Global Dihydroartemisinin Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dihydroartemisinin Sales Forecast by Application (2021-2026)
5.2.2 Global Dihydroartemisinin Revenue Forecast by Application (2021-2026)
5.2.3 Global Dihydroartemisinin Price Forecast by Application (2021-2026)
6 United States Dihydroartemisinin Market Facts & Figures
6.1 United States Dihydroartemisinin Sales Market Share by Company (2015-2020)
6.2 United States Dihydroartemisinin Sales Market Share by Type (2015-2020)
6.3 United States Dihydroartemisinin Sales Market Share by Application (2015-2020)
7 Europe Dihydroartemisinin Market Facts & Figures
7.1 Europe Dihydroartemisinin Sales Market Share by Company (2015-2020)
7.2 Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
7.3 Europe Dihydroartemisinin Sales Market Share by Application (2015-2020)
8 China Dihydroartemisinin Market Facts & Figures
8.1 China Dihydroartemisinin Sales Market Share by Company (2015-2020)
8.2 China Dihydroartemisinin Sales Market Share by Type (2015-2020)
8.3 China Dihydroartemisinin Sales Market Share by Application (2015-2020)
9 Japan Dihydroartemisinin Market Facts & Figures
9.1 Japan Dihydroartemisinin Sales Market Share by Company (3015-3030)
9.2 Japan Dihydroartemisinin Sales Market Share by Type (2015-2020)
9.3 Japan Dihydroartemisinin Sales Market Share by Application (2015-2020)
10 Southeast Asia Dihydroartemisinin Market Facts & Figures
10.1 Southeast Asia Dihydroartemisinin Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Dihydroartemisinin Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Dihydroartemisinin Sales Market Share by Application (2015-2020)
11 India Dihydroartemisinin Market Facts & Figures
11.1 India Dihydroartemisinin Sales Market Share by Company (2015-2020)
11.2 India Dihydroartemisinin Sales Market Share by Type (2015-2020)
11.3 India Dihydroartemisinin Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dihydroartemisinin Business
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Sanofi Dihydroartemisinin Products Offered
12.1.5 Sanofi Recent Development
12.2 KPC Pharmaceuticals
12.2.1 KPC Pharmaceuticals Corporation Information
12.2.2 KPC Pharmaceuticals Business Overview
12.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.2.4 KPC Pharmaceuticals Dihydroartemisinin Products Offered
12.2.5 KPC Pharmaceuticals Recent Development
12.3 Guangxi Xiancaotang Pharmaceutical
12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
12.3.2 Guangxi Xiancaotang Pharmaceutical Business Overview
12.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products Offered
12.3.5 Guangxi Xiancaotang Pharmaceutical Recent Development
12.4 Guilin Pharmaceutical
12.4.1 Guilin Pharmaceutical Corporation Information
12.4.2 Guilin Pharmaceutical Business Overview
12.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Guilin Pharmaceutical Dihydroartemisinin Products Offered
12.4.5 Guilin Pharmaceutical Recent Development
12.5 Kerui Nanhai Pharmaceutical
12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
12.5.2 Kerui Nanhai Pharmaceutical Business Overview
12.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products Offered
12.5.5 Kerui Nanhai Pharmaceutical Recent Development
12.6 Shanghai Natural Bio-engineering Co
12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
12.6.2 Shanghai Natural Bio-engineering Co Business Overview
12.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products Offered
12.6.5 Shanghai Natural Bio-engineering Co Recent Development
12.7 Novanat Bioresource
12.7.1 Novanat Bioresource Corporation Information
12.7.2 Novanat Bioresource Business Overview
12.7.3 Novanat Bioresource Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Novanat Bioresource Dihydroartemisinin Products Offered
12.7.5 Novanat Bioresource Recent Development
12.8 Botanical Extracts EPZ Ltd
12.8.1 Botanical Extracts EPZ Ltd Corporation Information
12.8.2 Botanical Extracts EPZ Ltd Business Overview
12.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products Offered
12.8.5 Botanical Extracts EPZ Ltd Recent Development
13 Dihydroartemisinin Manufacturing Cost Analysis
13.1 Dihydroartemisinin Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dihydroartemisinin
13.4 Dihydroartemisinin Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dihydroartemisinin Distributors List
14.3 Dihydroartemisinin Customers
15 Market Dynamics
15.1 Dihydroartemisinin Market Trends
15.2 Dihydroartemisinin Opportunities and Drivers
15.3 Dihydroartemisinin Market Challenges
15.4 Dihydroartemisinin Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dihydroartemisinin Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Dihydroartemisinin Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Dihydroartemisinin Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Dihydroartemisinin Sales (K MT) by Region (2015-2020)
Table 5. Global Dihydroartemisinin Sales Market Share by Region (2015-2020)
Table 6. Global Dihydroartemisinin Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Dihydroartemisinin Revenue Share by Region (2015-2020)
Table 8. Global Dihydroartemisinin Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Dihydroartemisinin Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Dihydroartemisinin Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Dihydroartemisinin Revenue Share Forecast by Region (2021-2026)
Table 12. Global Dihydroartemisinin (K MT) of Key Companies (2015-2020)
Table 13. Global Dihydroartemisinin Sales Share by Company (2015-2020)
Table 14. Global Dihydroartemisinin Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Dihydroartemisinin Revenue Share by Company (2015-2020)
Table 16. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2019)
Table 17. Global Dihydroartemisinin Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Dihydroartemisinin Manufacturing Sites and Area Served
Table 19. Manufacturers Dihydroartemisinin Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Dihydroartemisinin Players
Table 22. Global Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 23. Global Dihydroartemisinin Sales Share by Type (2015-2020)
Table 24. Global Dihydroartemisinin Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Dihydroartemisinin Price (K MT) by Type (2015-2020)
Table 26. Global Dihydroartemisinin Sales Share by Type (2021-2026)
Table 27. Global Dihydroartemisinin Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Dihydroartemisinin Revenue Share by Type (2021-2026)
Table 29. Global Dihydroartemisinin Price (K MT) by Type (2021-2026)
Table 30. Global Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 31. Global Dihydroartemisinin Sales Share by Application (2015-2020)
Table 32. Global Dihydroartemisinin Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Dihydroartemisinin Price (K MT) by Application (2015-2020)
Table 34. Global Dihydroartemisinin Sales (K MT) by Application (2021-2026)
Table 35. Global Dihydroartemisinin Sales Share by Application (2021-2026)
Table 36. Global Dihydroartemisinin Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Dihydroartemisinin Revenue Share by Application (2021-2026)
Table 38. Global Dihydroartemisinin Price (K MT) by Application (2021-2026)
Table 39. United States Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 40. United States Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 41. United States Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 42. United States Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 43. United States Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 44. United States Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 45. Europe Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 46. Europe Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 47. Europe Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 48. Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 49. Europe Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 50. Europe Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 51. China Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 52. China Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 53. China Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 54. China Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 55. China Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 56. China Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 57. Japan Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 58. Japan Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 59. Japan Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 60. Japan Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 61. Japan Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 62. Japan Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 69. India Dihydroartemisinin Sales (K MT) by Company (2015-2020)
Table 70. India Dihydroartemisinin Sales Market Share by Company (2015-2020)
Table 71. India Dihydroartemisinin Sales (K MT) by Type (2015-2020)
Table 72. India Dihydroartemisinin Sales Market Share by Type (2015-2020)
Table 73. India Dihydroartemisinin Sales (K MT) by Application (2015-2020)
Table 74. India Dihydroartemisinin Sales Market Share by Application (2015-2020)
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Sanofi Dihydroartemisinin Product
Table 79. Sanofi Recent Development
Table 80. KPC Pharmaceuticals Corporation Information
Table 81. KPC Pharmaceuticals Description and Business Overview
Table 82. KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. KPC Pharmaceuticals Dihydroartemisinin Product
Table 84. KPC Pharmaceuticals Recent Development
Table 85. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 86. Guangxi Xiancaotang Pharmaceutical Description and Business Overview
Table 87. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Product
Table 89. Guangxi Xiancaotang Pharmaceutical Recent Development
Table 90. Guilin Pharmaceutical Corporation Information
Table 91. Guilin Pharmaceutical Description and Business Overview
Table 92. Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Guilin Pharmaceutical Dihydroartemisinin Product
Table 94. Guilin Pharmaceutical Recent Development
Table 95. Kerui Nanhai Pharmaceutical Corporation Information
Table 96. Kerui Nanhai Pharmaceutical Description and Business Overview
Table 97. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Kerui Nanhai Pharmaceutical Dihydroartemisinin Product
Table 99. Kerui Nanhai Pharmaceutical Recent Development
Table 100. Shanghai Natural Bio-engineering Co Corporation Information
Table 101. Shanghai Natural Bio-engineering Co Description and Business Overview
Table 102. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Shanghai Natural Bio-engineering Co Dihydroartemisinin Product
Table 104. Shanghai Natural Bio-engineering Co Recent Development
Table 105. Novanat Bioresource Corporation Information
Table 106. Novanat Bioresource Description and Business Overview
Table 107. Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Novanat Bioresource Dihydroartemisinin Product
Table 109. Novanat Bioresource Recent Development
Table 110. Botanical Extracts EPZ Ltd Corporation Information
Table 111. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Botanical Extracts EPZ Ltd Description and Business Overview
Table 113. Botanical Extracts EPZ Ltd Dihydroartemisinin Product
Table 114. Botanical Extracts EPZ Ltd Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Dihydroartemisinin Distributors List
Table 118. Dihydroartemisinin Customers List
Table 119. Dihydroartemisinin Market Key Trends
Table 120. Dihydroartemisinin Key Opportunities and Drivers
Table 121. Dihydroartemisinin Market Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Dihydroartemisinin Product Picture
Figure 2. Global Dihydroartemisinin Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dihydroartemisinin Market Share by Application in 2020 & 2026
Figure 6. Malaria Treatment Examples
Figure 7. Scientific Research Examples
Figure 8. Others Examples
Figure 9. Global Dihydroartemisinin Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Dihydroartemisinin Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dihydroartemisinin Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Dihydroartemisinin Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dihydroartemisinin Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dihydroartemisinin Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dihydroartemisinin Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dihydroartemisinin Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dihydroartemisinin Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dihydroartemisinin Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dihydroartemisinin Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dihydroartemisinin Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dihydroartemisinin Players Market Share by Revenue in Dihydroartemisinin 2015 & 2019
Figure 27. Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dihydroartemisinin Revenue Share by Type (2015-2020)
Figure 29. Global Dihydroartemisinin Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dihydroartemisinin Revenue Share by Application (2015-2020)
Figure 31. Global Dihydroartemisinin Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dihydroartemisinin Sales Market Share by Type in 2019
Figure 33. United States Dihydroartemisinin Sales Market Share by Type in 2019
Figure 34. Europe Dihydroartemisinin Sales Market Share by Company in 2019
Figure 35. Europe Dihydroartemisinin Sales Market Share by Type in 2019
Figure 36. Europe Dihydroartemisinin Sales Market Share by Application in 2019
Figure 37. China Dihydroartemisinin Sales Market Share by Company in 2019
Figure 38. China Dihydroartemisinin Sales Market Share by Type in 2019
Figure 39. China Dihydroartemisinin Sales Market Share by Application in 2019
Figure 40. Japan Dihydroartemisinin Sales Market Share by Company in 2019
Figure 41. Japan Dihydroartemisinin Sales Market Share by Type in 2019
Figure 42. Japan Dihydroartemisinin Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dihydroartemisinin Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dihydroartemisinin Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dihydroartemisinin Sales Market Share by Application in 2019
Figure 46. India Dihydroartemisinin Sales Market Share by Company in 2019
Figure 47. India Dihydroartemisinin Sales Market Share by Type in 2019
Figure 48. India Dihydroartemisinin Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Dihydroartemisinin
Figure 51. Manufacturing Process Analysis of Dihydroartemisinin
Figure 52. Dihydroartemisinin Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
アルテミシニン誘導体の世界市場レポート2020 Market Analysis and Insights: Global Artemisinin Derivatives Market The global Artemisinin Derivatives market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Artemisinin Derivatives Scope and Market Size The global Artemisinin…- 製薬用PMCの世界市場レポート2020 Hydroxypropyl methylcellulose (HPMC) is a semisynthetic, inert, viscoelastic polymer used as eye drops, as well as a tablet coating, adhesive and controlled-delivery component in oral medicaments, found in a variety of commercial products. This report mainly covers Pharmaceutical Grade HPMC. In the …
- 製薬用フィコシアニンの世界市場レポート2020 Phycocyanin is a pigment-protein complex from the light-harvesting phycobiliprotein family, along with allophycocyanin and phycoerythrin. It is an accessory pigment to chlorophyll. All phycobiliproteins are water-soluble, so they cannot exist within the membrane like carotenoids can. Instead, phycob…
- 飼料用ビタミンDの世界市場レポート2020 This report studies the Feed Grade Vitamin D3 market, Vitamin D3, also known as cholecalciferol, is the chemical 9,10- seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol. Vitamin D3 occurs in and is isolated from fish liver oils. It also is manufactured by ultraviolet irradiation of 7-dehydrocholesterol prod…
- 医療用ビタミンDの世界市場レポート2020 Vitamin D3 is used for the prevention and treatment of vitamin D deficiency. It is also used for the treatment of chronic hypocalcemia, hypophosphatemia, rickets, and osteomalacia with chronic renal insufficiency, familial hypophosphatemia, and hypoparathyroidism. Market Analysis and Insights: Globa…